Paediatric HIV
Breakthrough Partners


Strategic Partnerships

Strategic partnerships are informed and shaped by developing and co-creating shared objectives towards a common outcome, aligned to broader HIV prevention and treatment goals, and the Positive Action strategy.

The thematic priority areas are as follows:

  • Ending paediatric AIDS.
  • Reducing new HIV transmissions in people who use drugs to zero in targeted settings#
  • Tackling HIV related stigma.
  • HIV prevention

The Breakthrough Paediatric partnership consisting of Positive Action, UNICEF, EGPAF, Aidsfonds, PATA, and community partners, is an example of a Positive Action supported Strategic Partnership.

The Breakthrough Partnership prioritises activities in five countries: Cameroon, Mozambique, Nigeria, Tanzania, and Uganda

The Breakthrough partners, working with government and community, aim to locate, link, treat and retain mothers and children at risk or living with HIV.

The purpose of the Breakthrough Partnership is to:

  • End paediatric AIDS in priority locations by implementing a high-quality package of sustainable and replicable interventions that is informed by the UNICEF Paediatric Service Delivery Framework
  • Build evidence around lessons learned from implementing programmes in order to support national scale of successful approaches.
  • Utilise the collective and catalytic value-add to engage in advocacy to amplify the voices of children and adolescents to end treatment inequalities in order to end AIDS by 2030.

The Partnership involves:

Phase I (July 2020- June 2023)

Year 1: Partnership building in Mozambique, Nigeria and Uganda.

Year 2: Partnership implementation.

Year 3: Further implementation, evaluation and recommendations for scaling up and knowledge sharing.

Phase II (July 2023-June 2026)

Year 1: Ongoing implementation in Mozambique and Nigeria, entering transition phase in Uganda, scoping Cameroon and Tanzania

Year 2: Ongoing implementation in Mozambique and Nigeria, transition out of Uganda, begin implementation in Cameroon and Tanzania

Year 3: Ongoing implementation in Mozambique, Nigeria, Cameroon and Tanzania


Community Strategic Initiatives seek to enable people and communities to improve the quality of life of people living with those most at risk of HIV.

NP-GBL-HVX-COCO-230010 | July 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.